The Israeli company recalled some vials of the drug in July 2009, and the FDA recently sent the company a warning letter about violations found at its Irvine, Calif., plant, according to the report.
APP Pharmaceuticals and Hospira are both manufacturing and distributing propofol. The FDA allowed APP to import a similar European product earlier this year after the American Society of Anesthesiologists raised concerns over the shortage.
Read the Wall Street Journal’s report on the propofol shortage.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
